Gp Act Iii Acquisition Stock Market Value
| GPAT Stock | 10.74 0.01 0.09% |
| Symbol | GPAT |
Is there potential for Diversified Financial Services market expansion? Will GPAT introduce new products? Factors like these will boost the valuation of GP Act. Market participants price GPAT higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about GP Act listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of GP Act III is measured differently than its book value, which is the value of GPAT that is recorded on the company's balance sheet. Investors also form their own opinion of GP Act's value that differs from its market value or its book value, called intrinsic value, which is GP Act's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because GP Act's market value can be influenced by many factors that don't directly affect GP Act's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GP Act's value and its price as these two are different measures arrived at by different means. Investors typically determine if GP Act is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GP Act's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
GP Act 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GP Act's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GP Act.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in GP Act on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding GP Act III Acquisition or generate 0.0% return on investment in GP Act over 90 days. GP Act is related to or competes with Centurion Acquisition, Berto Acquisition, Haymaker Acquisition, Bold Eagle, Cantor Equity, Voyager Acquisition, and M3 Brigade. GP Act is entity of United States. It is traded as Stock on NASDAQ exchange. More
GP Act Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GP Act's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GP Act III Acquisition upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.2364 | |||
| Information Ratio | (0.37) | |||
| Maximum Drawdown | 0.9368 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.1878 |
GP Act Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GP Act's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GP Act's standard deviation. In reality, there are many statistical measures that can use GP Act historical prices to predict the future GP Act's volatility.| Risk Adjusted Performance | 0.0174 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | (0.22) | |||
| Treynor Ratio | 0.0309 |
GP Act February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0174 | |||
| Market Risk Adjusted Performance | 0.0409 | |||
| Mean Deviation | 0.08 | |||
| Downside Deviation | 0.2364 | |||
| Coefficient Of Variation | 1240.6 | |||
| Standard Deviation | 0.1418 | |||
| Variance | 0.0201 | |||
| Information Ratio | (0.37) | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | (0.22) | |||
| Treynor Ratio | 0.0309 | |||
| Maximum Drawdown | 0.9368 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.1878 | |||
| Downside Variance | 0.0559 | |||
| Semi Variance | (0.0005) | |||
| Expected Short fall | (0.19) | |||
| Skewness | 0.1594 | |||
| Kurtosis | 4.54 |
GP Act III Backtested Returns
Currently, GP Act III Acquisition is very steady. GP Act III retains Efficiency (Sharpe Ratio) of 0.0969, which attests that the entity had a 0.0969 % return per unit of price deviation over the last 3 months. We have found twenty-five technical indicators for GP Act, which you can use to evaluate the volatility of the firm. Please check out GP Act's Market Risk Adjusted Performance of 0.0409, variance of 0.0201, and Downside Deviation of 0.2364 to validate if the risk estimate we provide is consistent with the expected return of 0.011%. GP Act has a performance score of 7 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 0.0462, which attests to not very significant fluctuations relative to the market. As returns on the market increase, GP Act's returns are expected to increase less than the market. However, during the bear market, the loss of holding GP Act is expected to be smaller as well. GP Act III today owns a risk of 0.11%. Please check out GP Act III Acquisition maximum drawdown, and the relationship between the standard deviation and expected short fall , to decide if GP Act III Acquisition will be following its current price history.
Auto-correlation | 0.07 |
Virtually no predictability
GP Act III Acquisition has virtually no predictability. Overlapping area represents the amount of predictability between GP Act time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GP Act III price movement. The serial correlation of 0.07 indicates that barely 7.0% of current GP Act price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | 0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.